New targets and approaches to autoimmune-induced salivary hypofunction

Douglas Dickinson, Kalu Ogbureke, Scott De Rossi, Stephen Hsu

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The pathogenesis of autoimmune diseases is multifaceted, and the complexity of symptoms, diagnosis and treatment options associated with these diseases reflects this. Sjogren's syndrome (SS) is an autoimmune disorder affecting up to 4 million Americans, and results from autoimmune reactions in secretory glands (primary SS) and other tissues (secondary SS). Current treatment options for SS are aimed largely at amelioration of symptoms, but without functional restoration in the secretory glands. Prescribed medications for salivary hypo-function or xerostomia are often associated with severe side effects, typically due to the effects of systemically administered muscarinic cholinergic receptor agonistis. This book presents research on novel agents for treatment of autoimmune disorders.
Original languageEnglish (US)
Title of host publicationAutoimmune Disorders: Symptoms, Diagnosis and Treatment
Subtitle of host publicationSymptoms, Diagnosis and Treatment
PublisherNova Science Publishers, Inc.
Pages143-166
Number of pages24
ISBN (Print)9781617615528
StatePublished - Jan 1 2011

Publication series

NameImmunology and Immune System Disorders
PublisherNova Science Publishers

Fingerprint

Sjogren's Syndrome
Xerostomia
Cholinergic Receptors
Muscarinic Receptors
Autoimmune Diseases
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dickinson, D., Ogbureke, K., Rossi, S. D., & Hsu, S. (2011). New targets and approaches to autoimmune-induced salivary hypofunction. In Autoimmune Disorders: Symptoms, Diagnosis and Treatment: Symptoms, Diagnosis and Treatment (pp. 143-166). (Immunology and Immune System Disorders). Nova Science Publishers, Inc..

New targets and approaches to autoimmune-induced salivary hypofunction. / Dickinson, Douglas; Ogbureke, Kalu; Rossi, Scott De; Hsu, Stephen.

Autoimmune Disorders: Symptoms, Diagnosis and Treatment: Symptoms, Diagnosis and Treatment. Nova Science Publishers, Inc., 2011. p. 143-166 (Immunology and Immune System Disorders).

Research output: Chapter in Book/Report/Conference proceedingChapter

Dickinson, D, Ogbureke, K, Rossi, SD & Hsu, S 2011, New targets and approaches to autoimmune-induced salivary hypofunction. in Autoimmune Disorders: Symptoms, Diagnosis and Treatment: Symptoms, Diagnosis and Treatment. Immunology and Immune System Disorders, Nova Science Publishers, Inc., pp. 143-166.
Dickinson D, Ogbureke K, Rossi SD, Hsu S. New targets and approaches to autoimmune-induced salivary hypofunction. In Autoimmune Disorders: Symptoms, Diagnosis and Treatment: Symptoms, Diagnosis and Treatment. Nova Science Publishers, Inc. 2011. p. 143-166. (Immunology and Immune System Disorders).
Dickinson, Douglas ; Ogbureke, Kalu ; Rossi, Scott De ; Hsu, Stephen. / New targets and approaches to autoimmune-induced salivary hypofunction. Autoimmune Disorders: Symptoms, Diagnosis and Treatment: Symptoms, Diagnosis and Treatment. Nova Science Publishers, Inc., 2011. pp. 143-166 (Immunology and Immune System Disorders).
@inbook{67bc0455f6144b99bd80cb710a6ad868,
title = "New targets and approaches to autoimmune-induced salivary hypofunction",
abstract = "The pathogenesis of autoimmune diseases is multifaceted, and the complexity of symptoms, diagnosis and treatment options associated with these diseases reflects this. Sjogren's syndrome (SS) is an autoimmune disorder affecting up to 4 million Americans, and results from autoimmune reactions in secretory glands (primary SS) and other tissues (secondary SS). Current treatment options for SS are aimed largely at amelioration of symptoms, but without functional restoration in the secretory glands. Prescribed medications for salivary hypo-function or xerostomia are often associated with severe side effects, typically due to the effects of systemically administered muscarinic cholinergic receptor agonistis. This book presents research on novel agents for treatment of autoimmune disorders.",
author = "Douglas Dickinson and Kalu Ogbureke and Rossi, {Scott De} and Stephen Hsu",
year = "2011",
month = "1",
day = "1",
language = "English (US)",
isbn = "9781617615528",
series = "Immunology and Immune System Disorders",
publisher = "Nova Science Publishers, Inc.",
pages = "143--166",
booktitle = "Autoimmune Disorders: Symptoms, Diagnosis and Treatment",

}

TY - CHAP

T1 - New targets and approaches to autoimmune-induced salivary hypofunction

AU - Dickinson, Douglas

AU - Ogbureke, Kalu

AU - Rossi, Scott De

AU - Hsu, Stephen

PY - 2011/1/1

Y1 - 2011/1/1

N2 - The pathogenesis of autoimmune diseases is multifaceted, and the complexity of symptoms, diagnosis and treatment options associated with these diseases reflects this. Sjogren's syndrome (SS) is an autoimmune disorder affecting up to 4 million Americans, and results from autoimmune reactions in secretory glands (primary SS) and other tissues (secondary SS). Current treatment options for SS are aimed largely at amelioration of symptoms, but without functional restoration in the secretory glands. Prescribed medications for salivary hypo-function or xerostomia are often associated with severe side effects, typically due to the effects of systemically administered muscarinic cholinergic receptor agonistis. This book presents research on novel agents for treatment of autoimmune disorders.

AB - The pathogenesis of autoimmune diseases is multifaceted, and the complexity of symptoms, diagnosis and treatment options associated with these diseases reflects this. Sjogren's syndrome (SS) is an autoimmune disorder affecting up to 4 million Americans, and results from autoimmune reactions in secretory glands (primary SS) and other tissues (secondary SS). Current treatment options for SS are aimed largely at amelioration of symptoms, but without functional restoration in the secretory glands. Prescribed medications for salivary hypo-function or xerostomia are often associated with severe side effects, typically due to the effects of systemically administered muscarinic cholinergic receptor agonistis. This book presents research on novel agents for treatment of autoimmune disorders.

UR - http://www.scopus.com/inward/record.url?scp=84892124403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892124403&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84892124403

SN - 9781617615528

T3 - Immunology and Immune System Disorders

SP - 143

EP - 166

BT - Autoimmune Disorders: Symptoms, Diagnosis and Treatment

PB - Nova Science Publishers, Inc.

ER -